Skip to content

Effects of 5-aminolevulinic acid supplementation during exercise training on improvements of physical fitness and lifestyle related diseases.

Effects of 5-aminolevulinic acid supplementation during exercise training on improvements of physical fitness and lifestyle related diseases. - Combined effects of exercise training and 5-aminolevulinic acid supplementation

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000029042
Enrollment
30
Registered
2017-09-07
Start date
2017-09-07
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

lifestyle related diseases

Interventions

5-aminolevulinic acid supplementtion(ALA). Subjects consumed a tablet of ALA(25mg) before breakfast and dinner every day for a month. The total amount of the supplement is 50mg/day. placebo supplemen

Sponsors

Shinshu University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1) Those who participated in the health promotion program for middle-aged and older citizens in Matsumoto and who suffer from life style related diseases, showing two of the following symptoms; systolic blood pressure is no less than 130mmHg, diastolic blood pressure is no less than 85 mmHg, or BMI is no less than 25kg/m2. 2) Those who can walk. 3) Those who show no alergic reaction to 5-aminolevulinic acid. 4) Those who agree to paricipate in the study after face to face explanation about the study by investigators and give their iformed consent.

Exclusion criteria

Exclusion criteria: 1) Those who do not clear the criteria above stated. 2) Those who a chief investigator judges inapproprite to participate in the study.

Design outcomes

Primary

MeasureTime frame
physical fitness (peak aerobic capacity, muscle strength, muscle volume), blood glucose control capacity

Countries

Japan

Contacts

Public ContactHiroshi Nose

Shinshu University Graduate School of Medicine

nosehir@shinshu-u.ac.jp0263-37-2681

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026